Tri-Institutional MD-PhD Program

Student Publications

2024

Zhang Z, Schaefer C, Jiang W, Lu Z, Lee J, Sziraki A, Abdulraouf A, Wick B, Haeussler M, Li Z et al.. 2024. A Panoramic View of Cell Population Dynamics in Mammalian Aging.. bioRxiv.

2024

Reichman M, Chen X, Lee A, Losner J, Thomas C, Katzen J. 2024. Yield of MR-directed US for MRI-detected breast findings: how often can we avoid MR biopsy? Clin Imaging. 111:110174.

2024

Nguyen T, Ong J, Masalkhi M, Waisberg E, Zaman N, Sarker P, Aman S, Lin H, Luo M, Ambrosio R et al.. 2024. Artificial intelligence in corneal diseases: A narrative review.. Cont Lens Anterior Eye. :102284.

2024

Schiffman JS, D'Avino AR, Prieto T, Pang Y, Fan Y, Rajagopalan S, Potenski C, Hara T, Suvà ML, Gawad C et al.. 2024. Defining heritability, plasticity, and transition dynamics of cellular phenotypes in somatic evolution.. Nat Genet. 56(10):2174-2184.

2024

Navrazhina K, Garcet S, Williams SC, Gulati N, Kiecker F, Frew JW, Mitsui H, Krueger JG. 2024. Laser capture microdissection provides a novel molecular profile of human primary cutaneous melanoma.. Pigment Cell Melanoma Res. 37(1):81-89.

2024

Singhal A, Styers HC, Rub J, Li Z, Torborg SR, Kim JYun, Grbovic-Huezo O, Feng H, Tarcan ZCagla, Ozkan HSahin et al.. 2024. A classical epithelial state drives acute resistance to KRAS inhibition in pancreas cancer.. Cancer Discov.

2024

Kazansky Y, Mueller HS, Cameron D, Demarest P, Zaffaroni N, Arrighetti N, Zuco V, Mundi PS, Kuwahara Y, Somwar R et al.. 2024. Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.. bioRxiv.

2024

Iannone AF, Akgül G, Zhang R, Wacks S, Hussein N, Macias CGinelly, Donatelle A, Bauriedel JMJ, Wright C, Abramov D et al.. 2024. The chemokine Cxcl14 regulates interneuron differentiation in layer I of the somatosensory cortex.. Cell Rep. 43(8):114531.

2024

Banh DV, Roberts CG, Morales-Amador A, Berryhill BA, Chaudhry W, Levin BR, Brady SF, Marraffini LA. 2024. Author Correction: Bacterial cGAS senses a viral RNA to initiate immunity.. Nature. 625(7993):E3.

2024

Kazansky Y, Cameron D, Mueller HS, Demarest P, Zaffaroni N, Arrighetti N, Zuco V, Kuwahara Y, Somwar R, Ladanyi M et al.. 2024. Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy.. Cancer Discov.

2024